A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Vitiligo is an autoimmune condition targeting melanocytes, necessitating effective preclinical models for therapeutic development.
• Existing vitiligo models have limitations in accurately reflecting human disease pathology and treatment responses.

Purpose of the Study:

• To introduce and validate a novel hairless hk14-SCF Tg mouse model for vitiligo research.
• To assess the utility of this model for preclinical evaluation of potential vitiligo therapies.

Main Methods:

• Vitiligo was induced in hairless hk14-SCF Tg mice via adoptive transfer of gp100-pulsed dendritic cells and PMEL CD8+ T cells, or by crossbreeding with PMEL TCR transgenic mice.
• Analysis involved immunohistochemistry, flow cytometry, bulk RNA sequencing, and cytokine assays to characterize the vitiligo phenotype.
• Therapeutic efficacy was evaluated using UV irradiation, topical corticosteroids, and a Jak inhibitor, with outcomes quantified by ImageJ analysis.

Main Results:

• The developed mouse model demonstrated melanocyte distribution similar to human skin.
• Disease mechanisms in the model recapitulated those observed in human vitiligo patients and prior animal models.
• All tested treatments (UV irradiation, corticosteroids, Jak inhibitor) significantly reduced vitiligo-affected skin areas.

Conclusions:

• The hairless hk14-SCF Tg mouse model provides a robust platform for studying vitiligo pathogenesis.
• This model overcomes limitations of previous systems, facilitating comprehensive preclinical testing of novel treatments.
• The findings support the potential for accelerated clinical translation of effective vitiligo therapies.